The market trends of the Bariatric Surgery industry have witnessed significant shifts in recent years, reflecting the evolving landscape of healthcare and the growing awareness of obesity-related health issues. Bariatric surgery, aimed at treating obesity and its associated complications, has experienced a notable surge in demand. One key trend is the increasing prevalence of obesity worldwide, contributing to the expanding market for bariatric procedures. As sedentary lifestyles and unhealthy dietary habits become more widespread, individuals are seeking effective and long-term solutions to manage their weight, driving the market growth.
Technological advancements have played a pivotal role in shaping the landscape of bariatric surgery. Minimally invasive techniques, such as laparoscopic and robotic-assisted surgeries, have gained prominence, offering patients shorter recovery times and reduced postoperative complications. These technological innovations not only enhance the overall patient experience but also attract more individuals to opt for bariatric procedures, boosting the market further. Surgeons and healthcare providers are increasingly adopting these advanced technologies, leading to a paradigm shift in the way bariatric surgeries are performed.
Another notable trend is the expanding acceptance of bariatric surgery as a viable and cost-effective treatment option for obesity-related comorbidities. Beyond just weight loss, bariatric procedures have shown positive outcomes in managing conditions like type 2 diabetes, hypertension, and sleep apnea. This broader scope of benefits has positioned bariatric surgery as a comprehensive solution for improving overall health and quality of life. As a result, more healthcare professionals are recommending and referring patients for bariatric interventions, contributing to the market's upward trajectory.
On a global scale, market dynamics are influenced by increasing healthcare expenditure and rising awareness of bariatric surgery as a sustainable weight management solution. Developed countries, in particular, are witnessing a surge in demand for these procedures, driven by a higher prevalence of obesity and greater accessibility to healthcare services. However, emerging economies are also catching up, with a growing middle class and increasing healthcare infrastructure. The evolving demographics and lifestyle changes in these regions are contributing to a notable uptick in bariatric surgery adoption.
Additionally, collaborations and partnerships within the healthcare ecosystem are shaping the market trends of bariatric surgery. Pharmaceutical companies, medical device manufacturers, and healthcare providers are forming strategic alliances to enhance patient care, develop innovative technologies, and expand market reach. Such collaborations not only drive research and development efforts but also streamline the integration of bariatric surgery into comprehensive obesity management programs.
However, challenges persist in the form of reimbursement issues and the high upfront costs associated with bariatric surgery. Despite the long-term benefits and cost-effectiveness in managing obesity-related complications, some healthcare systems face barriers in providing adequate reimbursement for these procedures. Overcoming these challenges is crucial for ensuring equitable access to bariatric surgery and sustaining market growth.
The Bariatric Surgery Market Size was valued at USD 1.8 billion in 2022 and is projected to grow from USD 1.9 Billion in 2023 to USD 3.82 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% during the forecast period (2024 - 2032). The increasing incidence of obesity among adults due to changing lifestyle habits and excess calorie intake is the primary driver for the bariatric surgery devices market. Furthermore, government support and increasing awareness about unhealthy foods and beverages in the market and their impact on BMI are expected to increase the demand for bariatric surgery over the forecast period. These are the key market drivers enhancing market growth.
Bariatric surgery is a sort of weight loss procedure that helps patients who are obese or highly overweight patients lose weight using various techniques. An inflatable medical device known as a gastric balloon, an intragastric balloon (IGB), or a gastric balloon is briefly put into the stomach to help with weight loss. The demand for balloons is fueled by several causes, including the launch of new products, a rise in patient awareness, partnerships with centers for bariatric surgery, and factory optimization to boost operating leverage. These procedures are intended to reduce the amount of nourishment that can be consumed, reduce the size of the stomach, and alter how efficiently the digestive system assimilates nutrients. Obesity is a big factor in this.
In recent years, obesity has become a major health concern on a global scale. Cardiovascular disease, certain malignancies, type 2 diabetes, and musculoskeletal diseases are just a few of the health issues that obesity is linked to. The global market share for bariatric procedures has grown significantly due to the procedure being a successful treatment choice for some obese people. The market for bariatric surgery is expanding due to the increased demand for weight loss procedures. In recent years, there has been a considerable increase in demand for weight loss operations due to the incidence of overweight and obesity continuing to climb around the globe. An upsurge in obesity amongst people and an increasing awareness of obesity are the main factors driving the bariatric surgery market's expansion.
People who have more body fat are much more prone to diabetes. Additionally, a range of tactics used by the key market participants, such as funding for research and development to widen the scope of bariatric surgery, promote market advancement. The main factor driving the market for bariatric surgical devices is the rising prevalence of obesity among people due to altered living patterns and excessive calorie intake. Over the forecast period, it is also anticipated that there will be an increase in demand for bariatric surgery due to government backing and growing public knowledge of the market's harmful products and how they affect BMI.
Gastric Solutions Inc., an innovative medical technology company, was granted approval by the FDA for their game-changing non-surgical bariatric procedure in June 2023. This development offers a less invasive option for suitable patients in need of bariatric intervention.
February 2023 saw Teleflex Incorporated announcing that it has secured a Group Purchasing Organization (GPO) agreement with Premier®, Inc. for its Titan SGS® powered stapling device to increase access to this ground-breaking technology for Premier-affiliated surgeons.
SlimFit Surgical Solutions, one of the major players in the market place announced early 2023 that it has launched an advanced robotic-assisted surgical system developed specifically for use during bariatric procedures.
September 2022 saw Teleflex Incorporated announce that it has completed its previously disclosed acquisition of Standard Bariatrics, Inc., which sells an innovative powered stapling technology utilized in gastric bypass surgeries.
Thus, to illustrate, from September 2021, Olympus launched POWERSEAL enhanced bipolar energy devices contributing towards Strengthening Surgical Portfolio. The POWERSEAL bipolar devices are useful in various forms of surgeries, including those used in weight loss operations. Moreover, in June 2021, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched ENSEAL X1 Curved Jaw Tissue Sealer for use in colorectal, gynecological, bariatric surgery and thoracic procedures.
For example, in May 2021, Standard Bariatrics (now part of Teleflex Corporation) announced that its novel Titan SGS stapling technology designed specifically for bariatric sleeve surgery has been cleared by the United States Food and Drug Administration (FDA). The first-of-its-kind design can be used by surgeons who are doing sleeve gastrectomy procedures as it offers an industry-leading continuous staple line measuring up to 23 cm. This is another factor driving market growth: introduction of such innovative products for bariatric surgeries. Also, the increase in the bariatric surgery market is due to the adoption of surgical techniques and technological advancement.
According to the World Health Organization's 2016 data review, 1.9 billion people worldwide are overweight, of which 650 million are obese. Nearly 13% of the population aged 18 and over are obese, and 41 million children under 5 are obese. The American Heart Association estimates total healthcare costs will increase from $861 billion to $957 billion by 2030. Colossal healthcare spending is forcing governments to take action to reduce the incidence of obesity and obesity-related long-term chronic diseases. It. In 2017, the U.S. Centers for Disease Control and Prevention (CDC) awarded approximately $8.5 million in funding to all 50 states and the District of Columbia to strengthen strategies to reduce obesity in areas with high obesity rates.
The market is primarily driven by the rising prevalence of obesity among adults and increasing operational efficiency by cutting-edge robotics. The National Institute for Health and Care Excellence (NICE) recommends bariatric surgery over lifestyle and medication and also recommends early consideration of surgery for people with diabetes. These developments are expected to drive market growth in the coming years. Moreover, increasing reimbursement coverage and sponsorship of bariatric surgery by local governments in developed countries is expected to drive market growth.
Obesity is one of the significant health concerns increasing the demand for gastric bypass surgery globally. Diabetes and cardiovascular disease are major diseases prevalent in the obese population. The emergence of new technologies in bariatric surgery, rising patient numbers, and growing demand for minimally invasive surgical procedures are the critical drivers for the growth of the bariatric surgery market over the forecast period. Therefore, the Bariatric Surgery market CAGR has been increasing globally in recent years. These are essential factors driving the growth of the Bariatric Surgery market revenue.
Based on the Device, the Bariatric Surgery Market segmentation includes surgical stapler gastric bands, gastric ballons, gastric emptying systems, and electrical stimulation systems. The gastric ballons segment held the majority share 2022 of the Bariatric Surgery Market revenue. New product launches, rising patient Awareness, collaborations with bariatric surgery centers, and manufacturing optimization to increase operating leverage are some factors driving the demand for balloons.
Based on Type, the Bariatric Surgery Market segmentation includes gastric bypass, sleeve gastrectomy, adjustable gastric band, and biliopancreatic diversion with duodenal switch. The sleeve gastrectomy segment held the majority share 2022 of the Bariatric Surgery Market revenue. Significant changes in lifestyle and eating habits, rise in public health concerns, rising burden of chronic diseases such as obesity and diabetes, growing focus on weight loss, and increasing demand for minimally invasive procedures are the major factors driving the segment's revenue growth. Gastric bypass surgery is one of the most widely performed bariatric procedures. This surgery reduces the risk of obesity-related life-threatening problems such as heart disease, stroke, high cholesterol, high blood pressure, type 2 diabetes, gastroesophageal reflux disease (GERD), infertility, and obstructive sleep apnea.
Figure 1: Bariatric Surgery Market by Type, 2022 & 2030 (USD billion)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Based on end-use, the global Bariatric Surgery industry has been segmented into Hospitals & Clinics, and Surgical centers. The surgical centers held the largest market share, commanding a whopping 57% market share in this segment. The growth is likely due to an increase in bariatric surgery globally. Hospital pharmacies are also expected to grow substantially during the forecast period.
News:
Using machine learning, a team of researchers from the University of Lille in Lille, Hauts-de-France, has developed a model that predicts specific weight trajectories for a maximum of five years after bariatric surgery. Three of the most common types of bariatric surgery include sleeve gastrectomy, RYGB (Roux-en-Y gastric bypass), and AGB (adjustable gastric banding). The model has been internationally verified and is being utilized for the very first time to deliver preoperative predictions of obesity trajectories for up to five years after surgery, based on a study released by THE LANCET Digital Health journal. Researchers claim it is challenging to anticipate how much fat will be lost following surgery since weight loss differs between people, surgeries, and over time. They stressed that an accurate forecast of the weight loss trajectory after bariatric surgery will assist patients and healthcare professionals in making clinical decisions.
By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Bariatric Surgery market accounted for USD 0.8 billion in 2022. It is expected to exhibit a significant CAGR growth during the study period due to Awareness of obesity and its risk factors and technological advances in laparoscopic bariatric surgery continuing to increase. The North American bariatric surgery market is the largest, followed by South America. Furthermore, obesity is one of the major health concerns among the U.S. population, thereby increasing the need for surgical procedures.
Further, the significant countries studied in the market report are The U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: BARIATRIC SURGERY MARKET SHARE BY REGION 2022 (%)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Europe's Bariatric Surgery market accounts for the second-largest market share. An increasing number of surgical equipment manufacturers and distributors, a high prevalence of diabetes, and massive government funding for research drive the European bariatric surgery market. Germany holds the largest market share, followed by France and the United Kingdom. Factors boosting the market's growth in Germany are the concentration of key players and their focus on diabetes and obesity management. Further, the Germany Bariatric Surgery market held the largest market share, and the U.K. Bariatric Surgery market was the fastest-growing market in the European Region.
The Asia-Pacific Bariatric Surgery Market is expected to grow at the fastest CAGR from 2024 to 2030. In the Asia-Pacific region, diabetes is one of the major chronic diseases that impose an economic burden on developing economies such as China and India. Availability of skilled healthcare professionals (i.e., surgeons), rising Awareness among patients about obesity, and rising geriatric population are key factors contributing to market growth. In India and China, the growing influence of the Western lifestyle, lack of physical activity, and sedentary lifestyle among the working population are major risk factors for obesity, accelerating market growth. Furthermore, the prevalence of obesity is also increasing in Asia Pacific, affecting the regional market. Moreover, the China Bariatric Surgery market held the largest market share, and the India Bariatric Surgery market was the fastest-growing market in the Asia-Pacific region.
Bariatric Surgery Key Market Players & Competitive Insights
Major market players are spending a lot on R&D to increase their product lines, which will help the Bariatric Surgery market grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the Bariatric Surgery industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
Manufacturing locally to reduce operating costs is one of the primary business strategies manufacturers adopt in the global Bariatric Surgery industry to benefit clients and expand the market sector. The Bariatric Surgery industry has provided medicine with some of the most significant benefits in recent years. Major players such as Apollo Endosurgery Inc., Johnson & Johnson Services Inc., Olympus Corporation, ALLERGAN, TransEnterix Surgical, Inc., Cousin Biotech in the Bariatric Surgery markets EndoGastric Solutions, Inc., and others are working on expanding the market demand by investing in research and development activities.
ReShape Lifesciences® is the world's premier weight loss solutions company, offering a comprehensive portfolio of proven products and services for managing and treating obesity and metabolic disease. In August 2022, ReShape Lifesciences™ received US FDA clearance for the GIBI HD gastrointestinal balloon indicator. The new solution includes three new sizes, viz. 32, 36, and 40, designed to simplify bariatric procedures such as laparoscopic sleeve gastrectomy, adjustable gastric banding, and gastric bypass surgery.
Also, Johnson & Johnson Services Inc. provides consumer healthcare products. The company offers healthcare products in feminine hygiene, baby care, facial skin care, beauty, wound care, cough and cold, oral care, and over-the-counter products. Johnson & Johnson Services serves clients worldwide. In June 2022, Johnson & Johnson rolled out the Echelon 3000, a next-gen stapler, in the US. The new digitally-enabled stapler aimed to offer surgeons simple and one-handed powered articulation. Moreover, the new solution also aids in addressing the root causes of several surgical complications to navigate the varying needs of each patient's anatomy successfully.
Key Companies in the Bariatric Surgery market include
Bariatric Surgery Industry Developments
January 2022: Titan SGS by Standard Bariatrics, Inc. has completed 1,000 clinical cases of use. Titan SGS, surgical stapler technology, benefits patients with an anatomically based approach in bariatric surgery.
July 2021: The U.S. Food and Drug Administration reauthorizes Apollo Endosurgery to market its Apollo ESG and Apollo REVISE endoscopic systems for the treatment of obese patients.
North America
Europe
Asia-Pacific
Rest of the World
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)